InvestorsHub Logo
Followers 19
Posts 3246
Boards Moderated 1
Alias Born 06/05/2020

Re: JoeForkeyBolo post# 18640

Thursday, 08/24/2023 12:36:19 AM

Thursday, August 24, 2023 12:36:19 AM

Post# of 20444
So a lil light on CEO comments if it helps.

The 1.4 BILLION $$ was this--https://www.hhs.gov/about/news/2023/08/22/funding-1-billion-vaccine-clinical-trials-326-million-new-monoclonal-antibody-100-million-explore-novel-vaccine-therapeuti-technologies.html. You can read where it went--not much toward therapeutics. I never know if this is U.S. based companies only but wish Todos would apply for any and all therapeutic trial or funding or whatever

The 3PL is 3rd party logistics (IMHO)--usually for backorders and inventory/stocking etc

The CID Journ article is "accepted" and members only to view. It is about a patient that was treated with long/repeat courses of Pax (and remdesevir/realdeathsevere)
as it says--"clinical and virologic failure". We need to hope this will only ever be in that 1 person. Not sure if this was 1st primary Dr or 9th Dr utilized--but failure pretty much sums it up.